Developer docs
API playgroundTry for free, no card

Search company profiles

Mediaire

Full company profile

uuid0000v2o

Namestring
Mediaire
Legal namestring
mediaire GmbH
Websiteurl
mediaire.de
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Mediaire GmbH is a Berlin-based medical imaging software company founded in 2018 that develops AI-powered diagnostic tools for magnetic resonance imaging (MRI). Its core platform, the md-suite, includes mdbrain (brain volumetry, lesion characterization, aneurysm detection and tumor differentiation), mdprostate (automated prostate MRI analysis with PI-RADS 2.1 classification), mdknee (knee MRI cartilage assessment per ICRS criteria), and SwiftMR. The products are built on proprietary deep-learning algorithms that automate segmentation, quantification, and reporting, and are integrated directly into the Picture Archiving and Communication Systems (PACS) used by hospitals and radiology practices.

The company sells to hospital radiology and neuroradiology departments, independent radiology practices, and imaging centers across Europe, with distribution both through direct enterprise sales and via PACS-vendor marketplaces such as the SECTRA AmplifierStore. Pricing is volume-based subscription billed monthly, with free trials available; the company emphasizes local data hosting for European data-residency compliance. As of November 2024 Mediaire reported deployment in over 350 hospitals and clinics with solutions covering approximately 24% of all MRIs across its installed base, and that monthly recurring revenue had tripled since Q1 2023.

The business is privately held and venture- and PE-backed, having raised approximately €12 million in a November 2024 round led by LBO France with participation from IBB Ventures, Wille Finance, HTGF, LIFTT, and Gateway Ventures. The company is led by CEO Dr. Andreas Lemke, with co-founder Jörg Döpfert as CTO. Recent strategic emphasis has been on expanding beyond neuro imaging into prostate and adjacent oncology workflows, evidenced by the 2024 launch of mdprostate and the March 2026 interoperability partnership with Mint Medical (an Snke OS company).

Short descriptiontext

Mediaire is a Berlin-based medical-imaging AI company founded in 2018 that builds deep-learning software (mdbrain, mdprostate, mdknee, SwiftMR) for automated MRI analysis, deployed in 350+ European hospitals and radiology practices on a volume-based subscription model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI MRI diagnostics, radiology software, brain volumetry software, prostate MRI analysis, PACS-integrated imaging
Industry2 codes
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code1 code
  • Software Publishers513210
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Radiology AI Software
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1MRI AI Diagnostic Software Subscriptions
TypeSubscription Recurring
Description

Volume-based subscription model where healthcare providers pay according to usage volume for AI-powered MRI diagnostic tools. The company reports transparent and flexible pricing without hidden costs.

mediaire.ai
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Volume-based subscription
ModelUsage-basedBilling cadenceMonthly
Notes

Customers pay according to volume of MRI analyses performed. No hidden costs. Risk-free trial available before commitment.

mediaire.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1md-suite
Description

AI-based software suite for MRI assessments covering brain, prostate, and knee diagnostics.

mediaire.ai
+4 more records
Core offering1 text field

Mediaire develops and sells AI-powered software for MRI diagnostics, offering an integrated suite (md-suite) of tools that automate brain volumetry, lesion characterization, aneurysm detection, tumor differentiation, prostate MRI classification (PI-RADS 2.1), and knee MRI cartilage assessment (ICRS). The software integrates directly into radiology PACS workflows and generates automated reports with norm value comparisons, targeting radiologists at hospitals, clinics, and independent imaging centers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Monthly recurring revenue tripled since Q1 2023
+3 more records
Product overview1 text field

Mediaire offers md-suite, a unified AI-powered platform for MRI diagnostics covering brain, prostate, and knee imaging. The platform includes three main products: mdbrain (brain MRI analysis with modules for brain volumetry, lesion characterization, aneurysm detection, and tumor differentiation), mdprostate (prostate MRI evaluation with PI-RADS 2.1 classification), and mdknee (automated knee MRI analysis with ICRS cartilage classification). Products are integrated into existing PACS workflows and generate automated reports with norm value comparisons. The company also offers SwiftMR as part of its product portfolio.

Product and service5 records
1md-suite
CategoryRadiology AI Platform
Description

Comprehensive AI-based software suite for MRI assessments covering brain, prostate, and knee diagnostics, integrating into existing PACS workflows and producing automatically generated reports with norm value comparisons.

2mdbrain
CategoryBrain MRI Analysis Software
Description

AI-based solution for quantitative neuro-imaging and brain MRI evaluation, providing automated brain volumetry, lesion characterization, aneurysm detection, and tumor differentiation for conditions including dementia, multiple sclerosis, gliomas, and metastases.

3mdprostate
CategoryProstate MRI Analysis Software
Description

AI-powered solution for automated prostate MRI diagnosis, providing static and longitudinal evaluation with automatic lesion detection and classification according to the PI-RADS 2.1 standard.

4mdknee
CategoryKnee MRI Analysis Software
Description

AI tool for automated analysis of knee MRIs, automatically classifying cartilage damage according to ICRS criteria with anatomical assignment, designed to handle repetitive assessment tasks in orthopedic radiology.

5SwiftMR
CategoryMRI Enhancement Software
Description

AI-powered MRI solution listed in the mediaire product portfolio alongside the md-suite products; specific capabilities not detailed in available source material.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-03-04
Description

Collaboration announced March 2026 to advance AI-powered MRI workflows through interoperability of Mint Medical's mint Lesion and Mediaire's mdprostate solutions. The partnership strengthens the prostate cancer care pathway by combining两家公司的AI技术优势。

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-05-03
Description

mdbrain is available at SECTRA AmplifierStore, enabling Mediaire to make AI-based solutions available to SECTRA customers globally. The partnership leverages SECTRA's PACS ecosystem for broader market reach.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

icometrix develops AI solutions for brain MRI analysis (including MS and dementia quantification) — a direct overlap with Mediaire's mdbrain product in the same clinical use cases and customer base of hospital radiology departments.

TypeDirect peer
Description

Cortechs.ai markets NeuroQuant, the leading FDA-cleared brain volumetry product for MRI, directly competing with Mediaire's mdbrain brain volumetry module among neuroradiology practices and hospitals.

TypeDirect peer
Description

Subtle Medical offers AI-powered MRI image enhancement and workflow tools (e.g., SubtleMR), serving the same radiology AI market for MRI diagnostics with adjacent use cases to Mediaire's md-suite.

TypeBroad incumbent
Description

Aidoc is a leading AI radiology platform covering multiple modalities and use cases across hospital systems; it competes with Mediaire in AI-driven diagnostic workflows and offers broader portfolio coverage.

TypeBroad incumbent
Description

RapidAI provides AI for stroke, aneurysm, and other neurovascular imaging; it overlaps with Mediaire's aneurysm detection and brain tumor differentiation modules within hospital radiology.

TypeBroad incumbent
Description

Viz.ai is a leading AI care coordination and imaging analytics platform that competes broadly with Mediaire in hospital radiology AI workflows, particularly in neurovascular indications.

TypeBroad incumbent
Description

Qure.ai develops AI for imaging diagnostics across multiple modalities and geographies; it overlaps with Mediaire in radiology AI for hospitals, with broader modality coverage.

TypeDirect peer
Description

Quibim provides AI-powered imaging biomarkers and radiology AI products with European roots; it competes with Mediaire in quantitative MRI analysis for hospital and research customers.

9Tempus AI (Arterys)
TypeEmerging player
Description

Tempus AI acquired Arterys, a pioneer in cloud-native MRI AI for cardiac and other imaging; it competes with Mediaire in MRI-focused radiology AI, now backed by Tempus's broader data and diagnostics platform.

TypeBroad incumbent
Description

Brainlab is a large imaging informatics and surgical software vendor serving hospital radiology and neurosurgery; it overlaps with Mediaire in MRI AI and PACS-adjacent workflows for hospitals.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mediaire

Radiology AI Softwaremediaire.de

Mediaire is a Berlin-based medical-imaging AI company founded in 2018 that builds deep-learning software (mdbrain, mdprostate, mdknee, SwiftMR) for automated MRI analysis, deployed in 350+ European hospitals and radiology practices on a volume-based subscription model.

What Mediaire does

Mediaire GmbH is a Berlin-based medical imaging software company founded in 2018 that develops AI-powered diagnostic tools for magnetic resonance imaging (MRI). Its core platform, the md-suite, includes mdbrain (brain volumetry, lesion characterization, aneurysm detection and tumor differentiation), mdprostate (automated prostate MRI analysis with PI-RADS 2.1 classification), mdknee (knee MRI cartilage assessment per ICRS criteria), and SwiftMR. The products are built on proprietary deep-learning algorithms that automate segmentation, quantification, and reporting, and are integrated directly into the Picture Archiving and Communication Systems (PACS) used by hospitals and radiology practices.

The company sells to hospital radiology and neuroradiology departments, independent radiology practices, and imaging centers across Europe, with distribution both through direct enterprise sales and via PACS-vendor marketplaces such as the SECTRA AmplifierStore. Pricing is volume-based subscription billed monthly, with free trials available; the company emphasizes local data hosting for European data-residency compliance. As of November 2024 Mediaire reported deployment in over 350 hospitals and clinics with solutions covering approximately 24% of all MRIs across its installed base, and that monthly recurring revenue had tripled since Q1 2023.

The business is privately held and venture- and PE-backed, having raised approximately €12 million in a November 2024 round led by LBO France with participation from IBB Ventures, Wille Finance, HTGF, LIFTT, and Gateway Ventures. The company is led by CEO Dr. Andreas Lemke, with co-founder Jörg Döpfert as CTO. Recent strategic emphasis has been on expanding beyond neuro imaging into prostate and adjacent oncology workflows, evidenced by the 2024 launch of mdprostate and the March 2026 interoperability partnership with Mint Medical (an Snke OS company).

Mediaire firmographics

Firmographics
Name
Mediaire
Legal name
mediaire GmbH
Website
https://mediaire.de
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
Mediaire is a Berlin-based medical-imaging AI company founded in 2018 that builds deep-learning software (mdbrain, mdprostate, mdknee, SwiftMR) for automated MRI analysis, deployed in 350+ European hospitals and radiology practices on a volume-based subscription model.
Ownership category
akta.pro rank

Mediaire industry classification

Industry
Product category
Radiology AI Software
NAICS
Software Publishers (513210)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • AI MRI diagnostics
  • Radiology software
  • Brain volumetry software
  • Prostate MRI analysis
  • PACS-integrated imaging

Where Mediaire is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Mediaire business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. MRI AI Diagnostic Software Subscriptions: Volume-based subscription model where healthcare providers pay according to usage volume for AI-powered MRI diagnostic tools. The company reports transparent and flexible pricing without hidden costs.

Pricing tiers

ModelBillingPrice
Usage-basedMonthlyVolume-based subscription

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Mediaire product offering

Product offering

Core offering

Mediaire develops and sells AI-powered software for MRI diagnostics, offering an integrated suite (md-suite) of tools that automate brain volumetry, lesion characterization, aneurysm detection, tumor differentiation, prostate MRI classification (PI-RADS 2.1), and knee MRI cartilage assessment (ICRS). The software integrates directly into radiology PACS workflows and generates automated reports with norm value comparisons, targeting radiologists at hospitals, clinics, and independent imaging centers.

Product overview

Mediaire offers md-suite, a unified AI-powered platform for MRI diagnostics covering brain, prostate, and knee imaging. The platform includes three main products: mdbrain (brain MRI analysis with modules for brain volumetry, lesion characterization, aneurysm detection, and tumor differentiation), mdprostate (prostate MRI evaluation with PI-RADS 2.1 classification), and mdknee (automated knee MRI analysis with ICRS cartilage classification). Products are integrated into existing PACS workflows and generate automated reports with norm value comparisons. The company also offers SwiftMR as part of its product portfolio.

Differentiator

Problem solved

Functional benefit

Brands

  • md-suite: AI-based software suite for MRI assessments covering brain, prostate, and knee diagnostics.
  • mdbrain
  • mdprostate
  • mdknee
  • SwiftMR

Products and services

  • md-suite Comprehensive AI-based software suite for MRI assessments covering brain, prostate, and knee diagnostics, integrating into existing PACS workflows and producing automatically generated reports with norm value comparisons.
  • mdbrain AI-based solution for quantitative neuro-imaging and brain MRI evaluation, providing automated brain volumetry, lesion characterization, aneurysm detection, and tumor differentiation for conditions including dementia, multiple sclerosis, gliomas, and metastases.
  • mdprostate AI-powered solution for automated prostate MRI diagnosis, providing static and longitudinal evaluation with automatic lesion detection and classification according to the PI-RADS 2.1 standard.
  • mdknee AI tool for automated analysis of knee MRIs, automatically classifying cartilage damage according to ICRS criteria with anatomical assignment, designed to handle repetitive assessment tasks in orthopedic radiology.
  • SwiftMR AI-powered MRI solution listed in the mediaire product portfolio alongside the md-suite products; specific capabilities not detailed in available source material.

Quantifiable outcome

  • Monthly recurring revenue tripled since Q1 2023
  • +3 more outcomes

Companies that use Mediaire

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Mediaire technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Mediaire partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Mint Medical (Snke company)coreTechnology or Integration · 4 March 2026Collaboration announced March 2026 to advance AI-powered MRI workflows through interoperability of Mint Medical's mint Lesion and Mediaire's mdprostate solutions. The partnership strengthens the prostate cancer care pathway by combining两家公司的AI技术优势。
  • SECTRAcoreTechnology or Integration · 3 May 2022mdbrain is available at SECTRA AmplifierStore, enabling Mediaire to make AI-based solutions available to SECTRA customers globally. The partnership leverages SECTRA's PACS ecosystem for broader market reach.

Scale indicators5 records

Recent moves5 records

Expansion highlights6 records

Mediaire competitors and assessment

Company assessment

Direct peers

  • icometrix: icometrix develops AI solutions for brain MRI analysis (including MS and dementia quantification) — a direct overlap with Mediaire's mdbrain product in the same clinical use cases and customer base of hospital radiology departments.
  • Cortechs.ai: Cortechs.ai markets NeuroQuant, the leading FDA-cleared brain volumetry product for MRI, directly competing with Mediaire's mdbrain brain volumetry module among neuroradiology practices and hospitals.
  • Subtle Medical: Subtle Medical offers AI-powered MRI image enhancement and workflow tools (e.g., SubtleMR), serving the same radiology AI market for MRI diagnostics with adjacent use cases to Mediaire's md-suite.
  • Quibim: Quibim provides AI-powered imaging biomarkers and radiology AI products with European roots; it competes with Mediaire in quantitative MRI analysis for hospital and research customers.

Broad incumbents

  • Aidoc: Aidoc is a leading AI radiology platform covering multiple modalities and use cases across hospital systems; it competes with Mediaire in AI-driven diagnostic workflows and offers broader portfolio coverage.
  • RapidAI: RapidAI provides AI for stroke, aneurysm, and other neurovascular imaging; it overlaps with Mediaire's aneurysm detection and brain tumor differentiation modules within hospital radiology.
  • Viz.ai: Viz.ai is a leading AI care coordination and imaging analytics platform that competes broadly with Mediaire in hospital radiology AI workflows, particularly in neurovascular indications.
  • Qure.ai: Qure.ai develops AI for imaging diagnostics across multiple modalities and geographies; it overlaps with Mediaire in radiology AI for hospitals, with broader modality coverage.
  • Brainlab: Brainlab is a large imaging informatics and surgical software vendor serving hospital radiology and neurosurgery; it overlaps with Mediaire in MRI AI and PACS-adjacent workflows for hospitals.

Emerging players

  • Tempus AI (Arterys): Tempus AI acquired Arterys, a pioneer in cloud-native MRI AI for cardiac and other imaging; it competes with Mediaire in MRI-focused radiology AI, now backed by Tempus's broader data and diagnostics platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Mediaire social profiles

Digital presence

Mediaire financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mediaire leadership team

Management profile

Number of profiles

Profiles3 records

Mediaire funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mediaire M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mediaire

What does Mediaire do?

Mediaire develops and sells AI-powered software for MRI diagnostics, offering an integrated suite (md-suite) of tools that automate brain volumetry, lesion characterization, aneurysm detection, tumor differentiation, prostate MRI classification (PI-RADS 2.1), and knee MRI cartilage assessment (ICRS). The software integrates directly into radiology PACS workflows and generates automated reports with norm value comparisons, targeting radiologists at hospitals, clinics, and independent imaging centers.

Is Mediaire a public or private company?

Mediaire is a private company. It is classified as venture growth investor backed and is currently operating.

When was Mediaire founded?

Mediaire was founded in 2018. It employs 51 to 100 people.

Where is Mediaire based?

Mediaire is headquartered in Berlin, Germany, in the Europe region.

How does Mediaire make money?

One revenue line is on record: MRI AI Diagnostic Software Subscriptions.

Who are Mediaire's main competitors?

Direct peers on record are icometrix, Cortechs.ai, Subtle Medical and Quibim. Broad incumbents are Aidoc, RapidAI, Viz.ai, Qure.ai and Brainlab. Tempus AI (Arterys) is listed as an emerging player.

Does Mediaire have an API?

No public API is recorded for Mediaire.

What industry is Mediaire in?

Mediaire's product category is Radiology AI Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Bebeezmediaire transforms radiology with AI, securing a European €12 million investment to fuel global growth – BeBeez Internationalmediaire, a German radiology AI company, secured a €12 million European-led financing round led by LBO France. The AI solutions are used in over 350 hospitals and clinics across Europe. The funding will support expansion beyond brain, prostate, and knee MRI diagnostics.PR Newswiremediaire transforms radiology with AI, securing a European €12 million investment to fuel global growthGerman radiology AI company mediaire has secured a €12 million European-led financing round, led by LBO France with participation from IBB Ventures, Wille Finance, and existing investors HTGF, LIFTT, and Gateway Ventures. The funding will support expansion of mediaire's AI portfolio beyond its current brain, prostate, and knee MRI diagnostics, building on its existing deployment in over 350 hospitals and clinics across Europe. CEO Dr. Andreas Lemke stated that the company's AI solutions are already being used by thousands of radiologists in hundreds of hospitals, and the investment will enable scaling to more healthcare providers globally.PR Newswiremediaire transforms radiology with AI, securing a European €12 million investment to fuel global growthmediaire secured a €12 million European-led financing round led by LBO France, with participation from IBB Ventures and Wille Finance. The German radiology AI company's solutions are used in over 350 hospitals and clinics across Europe. The funding will support expansion beyond brain, prostate, and knee MRI diagnostics.Mediairemediaire transforms radiology with AI, securing a European €12 million investment to fuel global growthmediaire, a German radiology AI company, secured a €12 million European-led financing round led by LBO France. The AI portfolio is already deployed in over 350 hospitals and clinics across Europe. The funding will expand its AI portfolio beyond brain, prostate, and knee MRI diagnostics.Nordic 9mediaire raises €2 million from High-Tech Gründerfonds (HTGF), primeCROWD and LIFFTmediaire, a Berlin-based MRI software developer, raised €2 million from HTGF, primeCROWD, and LIFFT. The capital will support sales and marketing, product development, and upselling. The company plans to expand into European markets from 2021 and international markets by 2023, broadening its product range beyond brain imaging.QMENTAQMENTA Partners with mediaire to Transform Brain ResearchQMENTA announced a partnership with mediaire to integrate the CE-marked mdbrain algorithm into its QMENTA Trials platform for brain disease research. The algorithm provides volumetry and lesion segmentation with superior performance and evaluation times compared to open-source biomarkers. The partnership aims to improve speed, precision, and accuracy in clinical trials.PR NewswireSmart Reporting & mediaire Join Forces to Streamline AI-Enhanced Diagnostic WorkflowsSmart Reporting and mediaire have partnered to integrate AI-powered quantitative image analysis with structured medical reporting for Multiple Sclerosis. This collaboration aims to streamline radiology workflows by providing pre-filled reports based on MRI lesion counts, thereby increasing productivity in clinical settings.